Global Pneumococcal Bacteria Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 23-Nov-2022
No. of pages: 102
Inquire Before Buying

Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Pneumococcal Bacteria Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Pneumococcal Bacteria Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Pneumococcal Bacteria Vaccine is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Pneumococcal Bacteria Vaccine include Merck, Sanofi, Sinopharm, Pfizer, Walvax and GSK, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Pneumococcal Bacteria Vaccine manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Pneumococcal Bacteria Vaccine market. Further, it explains the major drivers and regional dynamics of the global Pneumococcal Bacteria Vaccine market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Merck

- Sanofi

- Sinopharm

- Pfizer

- Walvax

- GSK

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Pneumococcal Bacteria Vaccine Segment by Type

- PPSV 23

- PCV 13

- PCV 10

Pneumococcal Bacteria Vaccine Segment by Application

- Infant

- Children

- Adult

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - China Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Pneumococcal Bacteria Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Pneumococcal Bacteria Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Pneumococcal Bacteria Vaccine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Pneumococcal Bacteria Vaccine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pneumococcal Bacteria Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Pneumococcal Bacteria Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Pneumococcal Bacteria Vaccine sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Merck, Sanofi, Sinopharm, Pfizer, Walvax and GSK, etc.

Global Pneumococcal Bacteria Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Market Segment by Type
1.2.1 Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 PPSV 23
1.2.3 PCV 13
1.2.4 PCV 10
1.3 Market Segment by Application
1.3.1 Global Pneumococcal Bacteria Vaccine Market Share by Application (2017 VS 2021 VS 2028)
1.3.2 Infant
1.3.3 Children
1.3.4 Adult
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Pneumococcal Bacteria Vaccine Market Size (2017-2028)
2.1.1 Global Pneumococcal Bacteria Vaccine Revenue (2017-2028)
2.1.2 Global Pneumococcal Bacteria Vaccine Sales (2017-2028)
2.2 Global Pneumococcal Bacteria Vaccine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.2.1 Global Pneumococcal Bacteria Vaccine Sales by Regions (2017-2022)
2.2.2 Global Pneumococcal Bacteria Vaccine Revenue by Regions (2017-2022)
2.3 Global Pneumococcal Bacteria Vaccine Market Size Forecast by Region
2.3.1 Global Pneumococcal Bacteria Vaccine Sales Forecast by Region (2023-2028)
2.3.2 Global Pneumococcal Bacteria Vaccine Revenue Forecast by Region (2023-2028)
2.4 Global Top Pneumococcal Bacteria Vaccine Regions (Countries) Ranking by Market Size
2.5 Pneumococcal Bacteria Vaccine Market Dynamics
2.5.1 Pneumococcal Bacteria Vaccine Market Trends
2.5.2 Pneumococcal Bacteria Vaccine Market Drivers
2.5.3 Pneumococcal Bacteria Vaccine Market Challenges
2.5.4 Pneumococcal Bacteria Vaccine Market Restraints
3 Competitive Landscape by Manufacturers
3.1 Global Top Pneumococcal Bacteria Vaccine Manufacturers by Sales (2017-2022)
3.1.1 Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (2017-2022)
3.1.2 Global Pneumococcal Bacteria Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global 5 and 10 Largest Manufacturers by Pneumococcal Bacteria Vaccine Sales in 2021
3.2 Global Top Manufacturers Pneumococcal Bacteria Vaccine by Revenue
3.2.1 Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Top Pneumococcal Bacteria Vaccine Manufacturers Covered: Ranking by Revenue
3.2.3 Global Pneumococcal Bacteria Vaccine Revenue Share by Manufacturers (2017-2022)
3.2.4 Global Pneumococcal Bacteria Vaccine Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumococcal Bacteria Vaccine as of 2021)
3.4 Global Pneumococcal Bacteria Vaccine Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Pneumococcal Bacteria Vaccine Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Pneumococcal Bacteria Vaccine Market
3.7 Key Manufacturers Pneumococcal Bacteria Vaccine Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Pneumococcal Bacteria Vaccine Market Size by Type
4.1 Global Pneumococcal Bacteria Vaccine Historic Market Review by Type (2017-2022)
4.1.1 Global Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2022)
4.1.2 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2022)
4.1.3 Pneumococcal Bacteria Vaccine Price by Type (2017-2022)
4.2 Global Pneumococcal Bacteria Vaccine Market Estimates and Forecasts by Type (2023-2028)
4.2.1 Global Pneumococcal Bacteria Vaccine Sales Forecast by Type (2023-2028)
4.2.2 Global Pneumococcal Bacteria Vaccine Revenue Forecast by Type (2023-2028)
4.2.3 Pneumococcal Bacteria Vaccine Price Forecast by Type (2023-2028)
5 Global Pneumococcal Bacteria Vaccine Market Size by Application
5.1 Global Pneumococcal Bacteria Vaccine Historic Market Review by Application (2017-2022)
5.1.1 Global Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2022)
5.1.2 Global Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2017-2022)
5.1.3 Pneumococcal Bacteria Vaccine Price by Application (2017-2022)
5.2 Global Pneumococcal Bacteria Vaccine Market Estimates and Forecasts by Application (2023-2028)
5.2.1 Global Pneumococcal Bacteria Vaccine Sales Forecast by Application (2023-2028)
5.2.2 Global Pneumococcal Bacteria Vaccine Revenue Forecast by Application (2023-2028)
5.2.3 Pneumococcal Bacteria Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Pneumococcal Bacteria Vaccine Sales Breakdown by Company
6.1.1 North America Pneumococcal Bacteria Vaccine Sales by Company (2017-2022)
6.1.2 North America Pneumococcal Bacteria Vaccine Revenue by Company (2017-2022)
6.2 North America Pneumococcal Bacteria Vaccine Market Size by Type
6.2.1 North America Pneumococcal Bacteria Vaccine Sales by Type (2017-2028)
6.2.2 North America Pneumococcal Bacteria Vaccine Revenue by Type (2017-2028)
6.3 North America Pneumococcal Bacteria Vaccine Market Size by Application
6.3.1 North America Pneumococcal Bacteria Vaccine Sales by Application (2017-2028)
6.3.2 North America Pneumococcal Bacteria Vaccine Revenue by Application (2017-2028)
6.4 North America Pneumococcal Bacteria Vaccine Market Size by Country
6.4.1 North America Pneumococcal Bacteria Vaccine Sales by Country (2017-2028)
6.4.2 North America Pneumococcal Bacteria Vaccine Revenue by Country (2017-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Pneumococcal Bacteria Vaccine Sales Breakdown by Company
7.1.1 Europe Pneumococcal Bacteria Vaccine Sales by Company (2017-2022)
7.1.2 Europe Pneumococcal Bacteria Vaccine Revenue by Company (2017-2022)
7.2 Europe Pneumococcal Bacteria Vaccine Market Size by Type
7.2.1 Europe Pneumococcal Bacteria Vaccine Sales by Type (2017-2028)
7.2.2 Europe Pneumococcal Bacteria Vaccine Revenue by Type (2017-2028)
7.3 Europe Pneumococcal Bacteria Vaccine Market Size by Application
7.3.1 Europe Pneumococcal Bacteria Vaccine Sales by Application (2017-2028)
7.3.2 Europe Pneumococcal Bacteria Vaccine Revenue by Application (2017-2028)
7.4 Europe Pneumococcal Bacteria Vaccine Market Size by Country
7.4.1 Europe Pneumococcal Bacteria Vaccine Sales by Country (2017-2028)
7.4.2 Europe Pneumococcal Bacteria Vaccine Revenue by Country (2017-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales Breakdown by Company
8.1.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Company (2017-2022)
8.1.2 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Company (2017-2022)
8.2 Asia Pacific Pneumococcal Bacteria Vaccine Market Size by Type
8.2.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Type (2017-2028)
8.2.2 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Type (2017-2028)
8.3 Asia Pacific Pneumococcal Bacteria Vaccine Market Size by Application
8.3.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Application (2017-2028)
8.3.2 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Application (2017-2028)
8.4 Asia Pacific Pneumococcal Bacteria Vaccine Market Size by Region
8.4.1 Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region
8.4.2 Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 China Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
9 Latin America
9.1 Latin America Pneumococcal Bacteria Vaccine Sales Breakdown by Company
9.1.1 Latin America Pneumococcal Bacteria Vaccine Sales by Company (2017-2022)
9.1.2 Latin America Pneumococcal Bacteria Vaccine Revenue by Company (2017-2022)
9.2 Latin America Pneumococcal Bacteria Vaccine Market Size by Type
9.2.1 Latin America Pneumococcal Bacteria Vaccine Sales by Type (2017-2028)
9.2.2 Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2017-2028)
9.3 Latin America Pneumococcal Bacteria Vaccine Market Size by Application
9.3.1 Latin America Pneumococcal Bacteria Vaccine Sales by Application (2017-2028)
9.3.2 Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2017-2028)
9.4 Latin America Pneumococcal Bacteria Vaccine Market Size by Country
9.4.1 Latin America Pneumococcal Bacteria Vaccine Sales by Country (2017-2028)
9.4.2 Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2017-2028)
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales Breakdown by Company
10.1.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Company (2017-2022)
10.1.2 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Company (2017-2022)
10.2 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Type
10.2.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2017-2028)
10.2.2 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Type (2017-2028)
10.3 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Application
10.3.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2017-2028)
10.3.2 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Application (2017-2028)
10.4 Middle East and Africa Pneumococcal Bacteria Vaccine Market Size by Country
10.4.1 Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2017-2028)
10.4.2 Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2017-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Company Profiles
11.1 Merck
11.1.1 Merck Corporation Information
11.1.2 Merck Overview
11.1.3 Merck Pneumococcal Bacteria Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.1.4 Merck Pneumococcal Bacteria Vaccine Products and Services
11.1.5 Merck Pneumococcal Bacteria Vaccine SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Pneumococcal Bacteria Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.2.4 Sanofi Pneumococcal Bacteria Vaccine Products and Services
11.2.5 Sanofi Pneumococcal Bacteria Vaccine SWOT Analysis
11.2.6 Sanofi Recent Developments
11.3 Sinopharm
11.3.1 Sinopharm Corporation Information
11.3.2 Sinopharm Overview
11.3.3 Sinopharm Pneumococcal Bacteria Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.3.4 Sinopharm Pneumococcal Bacteria Vaccine Products and Services
11.3.5 Sinopharm Pneumococcal Bacteria Vaccine SWOT Analysis
11.3.6 Sinopharm Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer Pneumococcal Bacteria Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.4.4 Pfizer Pneumococcal Bacteria Vaccine Products and Services
11.4.5 Pfizer Pneumococcal Bacteria Vaccine SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Walvax
11.5.1 Walvax Corporation Information
11.5.2 Walvax Overview
11.5.3 Walvax Pneumococcal Bacteria Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.5.4 Walvax Pneumococcal Bacteria Vaccine Products and Services
11.5.5 Walvax Pneumococcal Bacteria Vaccine SWOT Analysis
11.5.6 Walvax Recent Developments
11.6 GSK
11.6.1 GSK Corporation Information
11.6.2 GSK Overview
11.6.3 GSK Pneumococcal Bacteria Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)
11.6.4 GSK Pneumococcal Bacteria Vaccine Products and Services
11.6.5 GSK Pneumococcal Bacteria Vaccine SWOT Analysis
11.6.6 GSK Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Pneumococcal Bacteria Vaccine Value Chain Analysis
12.2 Pneumococcal Bacteria Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Pneumococcal Bacteria Vaccine Production Mode & Process
12.4 Pneumococcal Bacteria Vaccine Sales and Marketing
12.4.1 Pneumococcal Bacteria Vaccine Sales Channels
12.4.2 Pneumococcal Bacteria Vaccine Distributors
12.5 Pneumococcal Bacteria Vaccine Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
Table 1. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of PPSV 23
Table 3. Major Manufacturers of PCV 13
Table 4. Major Manufacturers of PCV 10
Table 5. Global Pneumococcal Bacteria Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Pneumococcal Bacteria Vaccine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 7. Global Pneumococcal Bacteria Vaccine Sales by Region (2017-2022) & (K Units)
Table 8. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2017-2022)
Table 9. Global Pneumococcal Bacteria Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region (2017-2022)
Table 11. Global Pneumococcal Bacteria Vaccine Sales Forecast by Region (2023-2028) & (K Units)
Table 12. Global Pneumococcal Bacteria Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 13. Global Pneumococcal Bacteria Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 14. Global Pneumococcal Bacteria Vaccine Revenue Market Share Forecast by Region (2023-2028)
Table 15. Top Pneumococcal Bacteria Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2021
Table 16. Pneumococcal Bacteria Vaccine Market Trends
Table 17. Pneumococcal Bacteria Vaccine Market Drivers
Table 18. Pneumococcal Bacteria Vaccine Market Challenges
Table 19. Pneumococcal Bacteria Vaccine Market Restraints
Table 20. Global Pneumococcal Bacteria Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 21. Global Pneumococcal Bacteria Vaccine Sales Share by Manufacturers (2017-2022)
Table 22. Global Pneumococcal Bacteria Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 23. Ranking of Global Top Pneumococcal Bacteria Vaccine Manufacturers by Revenue (US$ Million) in 2021
Table 24. Pneumococcal Bacteria Vaccine Revenue Share by Manufacturers (2017-2022)
Table 25. Global Pneumococcal Bacteria Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 26. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pneumococcal Bacteria Vaccine as of 2021)
Table 27. Key Manufacturers Pneumococcal Bacteria Vaccine Average Selling Price (ASP) & (2017-2022) & (US$/Unit)
Table 28. Key Manufacturers Pneumococcal Bacteria Vaccine Plants/Factories Distribution
Table 29. Key Manufacturers Pneumococcal Bacteria Vaccine Area Served
Table 30. Date of Key Manufacturers Enter into Pneumococcal Bacteria Vaccine Market
Table 31. Key Manufacturers Pneumococcal Bacteria Vaccine Product Type
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Pneumococcal Bacteria Vaccine Sales (K Units) by Type (2017-2022)
Table 34. Global Pneumococcal Bacteria Vaccine Sales Share by Type (2017-2022)
Table 35. Global Pneumococcal Bacteria Vaccine Revenue (US$ Million) Market Share by Type (2017-2022)
Table 36. Global Pneumococcal Bacteria Vaccine Price (K Units) by Type (2017-2022)
Table 37. Global Pneumococcal Bacteria Vaccine Sales (K Units) by Type (2023-2028)
Table 38. Global Pneumococcal Bacteria Vaccine Sales Share by Type (2023-2028)
Table 39. Global Pneumococcal Bacteria Vaccine Revenue (US$ Million) Market Share by Type (2023-2028)
Table 40. Global Pneumococcal Bacteria Vaccine Revenue Share by Type (2023-2028)
Table 41. Global Pneumococcal Bacteria Vaccine Price (K Units) by Type (2023-2028)
Table 42. Global Pneumococcal Bacteria Vaccine Sales (K Units) by Application (2017-2022)
Table 43. Global Pneumococcal Bacteria Vaccine Sales Share by Application (2017-2022)
Table 44. Global Pneumococcal Bacteria Vaccine Revenue (US$ Million) Market Share by Application (2017-2022)
Table 45. Global Pneumococcal Bacteria Vaccine Price (K Units) by Application (2017-2022)
Table 46. Global Pneumococcal Bacteria Vaccine Sales (K Units) by Application (2023-2028)
Table 47. Global Pneumococcal Bacteria Vaccine Sales Share by Application (2023-2028)
Table 48. Global Pneumococcal Bacteria Vaccine Revenue (US$ Million) Market Share by Application (2023-2028)
Table 49. Global Pneumococcal Bacteria Vaccine Revenue Share by Application (2023-2028)
Table 50. Global Pneumococcal Bacteria Vaccine Price (K Units) by Application (2023-2028)
Table 51. North America Pneumococcal Bacteria Vaccine Sales by Company (2017-2022) & (K Units)
Table 52. North America Pneumococcal Bacteria Vaccine Sales Market Share by Company (2017-2022)
Table 53. North America Pneumococcal Bacteria Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 54. North America Pneumococcal Bacteria Vaccine Revenue Market Share by Company (2017-2022)
Table 55. North America Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 56. North America Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 57. North America Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 58. North America Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 59. North America Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 60. North America Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 61. North America Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 62. North America Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 63. North America Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)
Table 64. North America Pneumococcal Bacteria Vaccine Sales by Country (2023-2028) & (K Units)
Table 65. North America Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 66. North America Pneumococcal Bacteria Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 67. Europe Pneumococcal Bacteria Vaccine Sales by Company (2017-2022) & (K Units)
Table 68. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Company (2017-2022)
Table 69. Europe Pneumococcal Bacteria Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 70. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Company (2017-2022)
Table 71. Europe Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 72. Europe Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 73. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 74. Europe Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 75. Europe Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 76. Europe Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 77. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 78. Europe Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 79. Europe Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)
Table 80. Europe Pneumococcal Bacteria Vaccine Sales by Country (2023-2028) & (K Units)
Table 81. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 82. Europe Pneumococcal Bacteria Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 83. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Company (2017-2022) & (K Units)
Table 84. Asia Pacific Pneumococcal Bacteria Vaccine Sales Market Share by Company (2017-2022)
Table 85. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 86. Asia Pacific Pneumococcal Bacteria Vaccine Revenue Market Share by Company (2017-2022)
Table 87. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 88. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 89. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 90. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 91. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 92. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 93. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 94. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 95. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2017-2022) & (K Units)
Table 96. Asia Pacific Pneumococcal Bacteria Vaccine Sales by Region (2023-2028) & (K Units)
Table 97. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 98. Asia Pacific Pneumococcal Bacteria Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 99. Latin America Pneumococcal Bacteria Vaccine Sales by Company (2017-2022) & (K Units)
Table 100. Latin America Pneumococcal Bacteria Vaccine Sales Market Share by Company (2017-2022)
Table 101. Latin America Pneumococcal Bacteria Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 102. Latin America Pneumococcal Bacteria Vaccine Revenue Market Share by Company (2017-2022)
Table 103. Latin America Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 104. Latin America Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 105. Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 106. Latin America Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 107. Latin America Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 108. Latin America Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 109. Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 110. Latin America Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 111. Latin America Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)
Table 112. Latin America Pneumococcal Bacteria Vaccine Sales by Country (2023-2028) & (K Units)
Table 113. Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 114. Latin America Pneumococcal Bacteria Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 115. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Company (2017-2022) & (K Units)
Table 116. Middle East and Africa Pneumococcal Bacteria Vaccine Sales Market Share by Company (2017-2022)
Table 117. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 118. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue Market Share by Company (2017-2022)
Table 119. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2017-2022) & (K Units)
Table 120. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Type (2023-2028) & (K Units)
Table 121. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 122. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 123. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2017-2022) & (K Units)
Table 124. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Application (2023-2028) & (K Units)
Table 125. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2017-2022) & (K Units)
Table 128. Middle East and Africa Pneumococcal Bacteria Vaccine Sales by Country (2023-2028) & (K Units)
Table 129. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 130. Middle East and Africa Pneumococcal Bacteria Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 131. Merck Corporation Information
Table 132. Merck Description and Overview
Table 133. Merck Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 134. Merck Pneumococcal Bacteria Vaccine Product and Services
Table 135. Merck Pneumococcal Bacteria Vaccine SWOT Analysis
Table 136. Merck Recent Developments
Table 137. Sanofi Corporation Information
Table 138. Sanofi Description and Overview
Table 139. Sanofi Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 140. Sanofi Pneumococcal Bacteria Vaccine Product and Services
Table 141. Sanofi Pneumococcal Bacteria Vaccine SWOT Analysis
Table 142. Sanofi Recent Developments
Table 143. Sinopharm Corporation Information
Table 144. Sinopharm Description and Overview
Table 145. Sinopharm Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 146. Sinopharm Pneumococcal Bacteria Vaccine Product and Services
Table 147. Sinopharm Pneumococcal Bacteria Vaccine SWOT Analysis
Table 148. Sinopharm Recent Developments
Table 149. Pfizer Corporation Information
Table 150. Pfizer Description and Overview
Table 151. Pfizer Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 152. Pfizer Pneumococcal Bacteria Vaccine Product and Services
Table 153. Pfizer Pneumococcal Bacteria Vaccine SWOT Analysis
Table 154. Pfizer Recent Developments
Table 155. Walvax Corporation Information
Table 156. Walvax Description and Overview
Table 157. Walvax Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 158. Walvax Pneumococcal Bacteria Vaccine Product and Services
Table 159. Walvax Pneumococcal Bacteria Vaccine SWOT Analysis
Table 160. Walvax Recent Developments
Table 161. GSK Corporation Information
Table 162. GSK Description and Overview
Table 163. GSK Pneumococcal Bacteria Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)
Table 164. GSK Pneumococcal Bacteria Vaccine Product and Services
Table 165. GSK Pneumococcal Bacteria Vaccine SWOT Analysis
Table 166. GSK Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Pneumococcal Bacteria Vaccine Distributors List
Table 170. Pneumococcal Bacteria Vaccine Customers List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Bacteria Vaccine Product Picture
Figure 2. Global Pneumococcal Bacteria Vaccine Sales Market Share by Type in 2021 & 2028
Figure 3. PPSV 23 Product Picture
Figure 4. PCV 13 Product Picture
Figure 5. PCV 10 Product Picture
Figure 6. Global Pneumococcal Bacteria Vaccine Sales Market Share by Application in 2021 & 2028
Figure 7. Infant Use Case
Figure 8. Children Use Case
Figure 9. Adult Use Case
Figure 10. Pneumococcal Bacteria Vaccine Report Years Considered
Figure 11. Global Pneumococcal Bacteria Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Pneumococcal Bacteria Vaccine Market Size 2017-2028 (US$ Million)
Figure 13. Global Pneumococcal Bacteria Vaccine Sales (2017-2022) & (K Units)
Figure 14. Global Pneumococcal Bacteria Vaccine Market Size Market Share by Region: 2021 VS 2028
Figure 15. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region (2017-2022)
Figure 16. Global Pneumococcal Bacteria Vaccine Sales Market Share by Region in 2021
Figure 17. Global Pneumococcal Bacteria Vaccine Revenue Market Share by Region in 2017 VS 2021
Figure 18. Global Pneumococcal Bacteria Vaccine Sales Share by Manufacturers in 2021
Figure 19. The 5 and 10 Largest Manufacturers in the World: Market Share by Pneumococcal Bacteria Vaccine Sales in 2021
Figure 20. Pneumococcal Bacteria Vaccine Revenue Share by Manufacturers in 2021
Figure 21. Pneumococcal Bacteria Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 22. Global Pneumococcal Bacteria Vaccine Revenue Share by Type (2017-2022)
Figure 23. Global Pneumococcal Bacteria Vaccine Revenue Growth Rate by Type in 2017 & 2021
Figure 24. Global Pneumococcal Bacteria Vaccine Revenue Share by Application (2017-2022)
Figure 25. Global Pneumococcal Bacteria Vaccine Revenue Growth Rate by Application in 2017 & 2021
Figure 26. North America Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2028)
Figure 27. North America Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2028)
Figure 28. North America Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2028)
Figure 29. North America Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2017-2028)
Figure 30. North America Pneumococcal Bacteria Vaccine Sales Share by Country (2017-2028)
Figure 31. North America Pneumococcal Bacteria Vaccine Revenue Share by Country (2017-2028)
Figure 32. United States Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 33. Canada Pneumococcal Bacteria Vaccine Revenue (2017-2028) & (US$ Million)
Figure 34. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Type (2017-2028)
Figure 35. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Type (2017-2028)
Figure 36. Europe Pneumococcal Bacteria Vaccine Sales Market Share by Application (2017-2028)
Figure 37. Europe Pneumococcal Bacteria Vaccine Revenue Market Share by Application (2017-2028)
Figure 38. Europe Pneumococcal Bacteria Vaccine
  • Global Genitourinary Partnering 2010-2022: Deal trends, players and financials
    Published: 01-Dec-2022        Price: US 3995 Onwards        Pages: 400
    Global Genitourinary Partnering 2010 to 2022 provides the full collection of genitourinary disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in genitourinary partnering deals Financial deal terms for headline, upfront and royalty by stage of development Genitourinary partnering agreement structure Genitourinary partnering contract documents Top genitourinary deals by value Most active genitourinary d......
  • Global Noscapine Base Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 101
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Noscapine Base manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publi......
  • Global Specialty Generics Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 113
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Specialty Generics companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry expert......
  • Global Generic and Biosimilar Pharmaceuticals Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 118
    Report Scope This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Generic and Biosimilar Pharmaceuticals companies, distributors, end users, industry associations, governments' industry bureaus, industry publicati......
  • Global Secondary Antibody Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 111
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Secondary Antibody manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry p......
  • Global Primary Antibody Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 115
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Primary Antibody manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry pub......
  • Global Animal Troponin Antibody Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 126
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Animal Troponin Antibody manufacturers, distributors, end users, industry associations, governments' industry bureaus, indu......
  • Global Human Troponin Antibody Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 127
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Human Troponin Antibody manufacturers, distributors, end users, industry associations, governments' industry bureaus, indus......
  • Global Troponin Antibody Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
    Published: 30-Nov-2022        Price: US 5600 Onwards        Pages: 125
    Report Scope This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Troponin Antibody manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry pu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs